In a new job - April 13, 2026
CTC welcomes two new board members
Pernilla Sandwall and Marie Gårdmark bring extensive senior leadership experience from the life sciences sector with special focus on clinical research and regulatory strategy in pharma/medtech development.
Clinical Trials - April 13, 2026
Mendus starts clinical program in chronic myeloid leukemia
The company has completed preparations and received all regulatory approvals for the VITAL-CML trial.
Biotech Business - April 13, 2026
Alligator Bioscience gives update on mitazalimab
In parallel with ongoing partnering activities, Alligator is exploring alternative opportunities for phase 3 development of mitazalimab in first line metastatic pancreatic cancer.
Clinical Trials - April 13, 2026
Diamyd Medical discontinues Phase 3 trial and initiates strategic review
Diamyd Medical has announced that it will discontinue the Phase 3 DIAGNODE-3 trial evaluating retogatein (rhGAD65) in Stage 3 type 1 diabetes.
Acquisition - April 13, 2026
Getinge acquires Pennamed
Getinge has acquired Pennamed, a UK-based distributor of endoscopic consumables serving National Health Service (NHS) and independent healthcare providers.
In a new job - April 10, 2026
Malin Grape becomes Special Advisor to WHO
Grape is to be appointed Special Advisor on antimicrobial resistance (AMR) to the WHO European Region.
